MicroPort® Orthopedics Attends 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

Las Vegas, the US – The 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting took place recently. As the world’s most authoritative and influential orthopedic event, this year’s AAOS gathered in Las Vegas nearly 30,000 orthopedic surgeons from across the world to share cutting-edge scientific information and discuss different academic views. MicroPort® Orthopedics presented its major hip and knee products at the event and showcased the products’ outstanding clinical performance and scientific outcome through innovation symposium and instrument demonstration.

Founded as a not-for-profit organization in 1933, the AAOS has grown from a small organization serving less than 500 members to the world's largest medical association of musculoskeletal specialists. The Academy now serves more than 39,000 members worldwide. The AAOS provides education and practice management services for orthopedic surgeons and allied health professionals. It also serves as an advocate for improved patient care and informs the public about the science of orthopedics.

At the annual meeting, Jimmy Chow M.D. from Abrazo Scottsdale Campus, who is one of those inventing the popular minimally invasive hip arthroplasty technique of Supercapsular Percutaneously Assisted Total Hip Arthroplasty (“SuperPATH®”), presented the technical key points of the SuperPATH® procedure with the help of vivid animation demonstration and surgery video clips in a speech “Superior Results: SuperPATH® Technique for Total Hip Arthroplasty”. He said that clinical follow-up studies showed that the SuperPATH® procedure’s incidence rates of post-operative dislocation, deep venous thrombosis and deep infection were below 1%. The SuperPATH® technique is successfully applied in not only primary arthroplasties but also revision cases: all the revision cases of him adopted the SuperPATH® approach, with less than 10% of the patients turning back to the conventional approaches. Meanwhile, he stressed that the SuperPATH® technique is one with safety and reliability on the basis of over 15 years of clinical experience. It uses the interval between the gluteus medius and piriformis and allows doctors to preserve or release the piriformis. As a result, the patients can have a fast recovery and reduce post-operative complications.

David Scott M.D. from Orthopaedic Specialty Clinic of Spokane in the US released the latest results of a research on Medial-Pivot Knee Implant (“Medial-Pivot Knee”). The research initiated a follow-up study on 100 post-stabilized implant cases and 101 Medial-Pivot implant cases. The results showed that the Medial-Pivot implant significantly outperformed post-stabilized implants in terms of post-operative flexion, pain/range of motion scores in Knee Society Score (KSS), and Forgotten Joint Score (FJS). The results demonstrated that compared to the conventional post-stabilized implants, Medial-Pivot Knee can not only help restore better post-operative motion to the patients, but leave the patients “forgetting” the knee surgeries, to improve their post-operative satisfaction.

During the annual meeting, a new member of the MicroPort® Orthopedics Medial-Pivot Knee family, the most recently developed Evolution Revision System, officially debuted. The MicroPort® Orthopedics Medial-Pivot Knee not only possesses over 20 years of outstanding primary arthroplasty experience, but also obtained reliable clinical verification for its revision system. MicroPort® Orthopedics also presented the technical rationale and respective advantages of SuperPATH® and DAA and introduced to the healthcare professionals in attendance the design characteristics and application methods of the relevant instruments for SuperPATH®, drawing the attention of many an international healthcare professional. MicroPort® Orthopedics is constantly committed to the R&D and promotion of new orthopedic techniques, rationales and products. In the future, the company will continue to team up with the global clinicians to contribute to the development of orthopedic cause and provide the patients suffering orthopedic diseases with the innovative therapeutic solutions, which can improve their quality of life.